With more than 100 of the world’s leading healthcare companies choosing us to manage their portfolio, it is no surprise we have dedicated and specialist sales teams that focus wholly upon one product range. There is no crossover, so our teams become an extension of our partners’ operations, and experts in that particular field.
Over the past two decades we have continually grown the business through a combination of organic growth of existing product portfolios, entry into new geographical markets and by means of acquisition, most notably Aquilant Ltd in 2018, Xograph in 2019 and Cardio Solutions in 2020. In 2021, Healthcare 21 was acquired by the AddLife AB Group. AddLife is a publicly listed Swedish Medtech company active across the European market.